FLUKE JOHN M JR 4

What Happened

• John M. Fluke Jr, a director of LeonaBio, received an award on April 9, 2026 consisting of derivative rights covering 28,000 shares. The grant reports a $0.00 acquisition price (no cash paid) and is recorded as an award/grant (derivative), not an open-market purchase or sale.

Key Details

• Transaction date: April 9, 2026; Form 4 filed April 13, 2026 (timely within required window).
• Instrument: Award/grant of derivative securities covering 28,000 shares; reported price $0.00; total reported cash value $0.
• Shares owned after transaction: Not specified in the filing.
• Footnote: The shares subject to the option vest monthly over 24 months from the grant date, contingent on continued service under the Issuer's 2026 Equity Incentive Plan.
• Filing status: Timely filed (no late-report indicator).

Context

• This was a compensation grant (derivative award of options), not an outright purchase or sale of common stock. Such grants are routine for service providers and align incentives over time since vesting is contingent on continued service. Because this is an award rather than a purchase, it does not by itself indicate an immediate bullish or bearish signal from the insider.